Full-Time

Senior Product Manager

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

Healthcare technology using AI for patient outcomes

Compensation Overview

$110k - $160k/yr

+ Incentive Compensation + Restricted Stock Units

Senior

Company Historically Provides H1B Sponsorship

Chicago, IL, USA

The expected salary range is applicable if the role is performed from Illinois and may vary for other locations.

Category
Product Management
Product
Required Skills
Product Management
Requirements
  • 5+ years’ experience working directly with software engineering teams -- preferably in a product management or business analyst type of role
  • BA/BS degree in a technical or clinical field, OR equivalent practical experience
  • Some light programming experience or general technical aptitude
  • Ability to work autonomously with a balanced team approach – you don't need to wait for directions, but know when buy-in is critical
  • Attention to detail and comfort optimizing and improving processes and the overall approach where necessary
  • Dynamic problem-solving skills and a love for figuring out solutions
  • An entrepreneurial spirit and excited to work on complex problems at scale
  • Understanding of physician and hospital dynamics and the constantly evolving healthcare landscape
  • Experience with HIPAA Compliance
Responsibilities
  • Lead the Platform product team and roadmap, fostering a culture of innovation, collaboration, and continuous improvement.
  • Champion the company values and the product vision (*the right care for the right patient at the right time*)
  • Acquire deep knowledge of the platform requirements and represent its needs across business units and within AI Apps
  • Provide guidance and support to the engineering team as they execute development work
  • Create, coordinate and execute roadmap initiatives through detailed feature requirements for the engineering, QA, and design teams to fully understand the scope of functionality and business drivers, so they can estimate and deliver in a timely manner with high-quality
  • Dive into the details – from business logic to the high-level technical perspective – effectively turning high-level ideas and requirements into functional/technical specifications
  • Effectively communicate and collaborate with all groups in the organization over the entire product development lifecycle from requirements gathering to release to rollout training (Reporting, Account Management, Engineering, Sales, and Research teams)
  • Collaborate and work with the Compliance team to ensure continuing compliance and service as security contact for the Product team
Desired Qualifications
  • Experience in life sciences, trials, care pathway automation, clinical research and/or precision medicine
  • Experience with GCP and/or AWS
  • Experience developing Gen AI software solutions

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Deep 6 AI expands Tempus' data network and precision medicine capabilities.
  • Partnership with Stemline Therapeutics strengthens Tempus' position in personalized cancer treatment.
  • Collaboration with Artera expands Tempus' reach in oncology diagnostics.

What critics are saying

  • Integration challenges with Deep 6 AI may lead to operational inefficiencies.
  • $560 million debt increases financial leverage, posing a risk if growth falters.
  • Regulatory hurdles may arise in expanding DNA profiling beyond cancer with Illumina.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids in personalized cancer treatment through advanced data insights.
  • Tempus collaborates with leading biotech firms to enhance drug development processes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
SDBN
Apr 15th, 2025
Illumina teams up with Tempus to expand DNA profiling beyond cancer

Illumina teams up with Tempus to expand DNA profiling beyond cancer.

Life Care News
Mar 30th, 2025
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting

Tempus exhibits 4 abstracts at the 2025 American College of Cardiology Annual Meeting.

Tempus
Mar 12th, 2025
Tempus Announces Acquisition of Deep 6 AI | Tempus AI

Deep 6 is integrated with over 750 provider site locations spanning more than 30 million patients, which will materially add to Tempus’ existing network CHICAGO --(BUSINESS WIRE)--Mar. 11, 2025-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision

TipRanks
Mar 12th, 2025
Tempus AI (TEM) Strengthens Precision Medicine with Deep 6 AI Deal, Cathie Wood Buys the Dip

Tempus AI has acquired Deep 6 AI to expand its reach and enhance offerings in precision medicine.

Business Wire
Feb 25th, 2025
Ares Management Upsizes Tempus Debt Facilities to $560 Million

Combined with $260 million of capital provided in 2022 and 2023, Ares Credit funds have provided Tempus a total debt package of approximately $560 million.